← Back to Analyst Consensus 
BLRX N/A
BioLineRx Ltd.
Current Price —
Implied Upside —
Analysts 0
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $26 | 44% |
| May 30, 2025 | Jones Trading | upgrade | Hold → Buy | $12 | 50% |
| May 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $26 | 44% |
| Apr 2, 2025 | Jones Trading | downgrade | Buy → Hold | $0 | 50% |
| Mar 31, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| May 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Apr 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Mar 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Feb 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Nov 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Sep 15, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $21 | 44% |
| Aug 31, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| May 25, 2023 | Oppenheimer | reiterate | — → Outperform | $4 | 52% |
| Feb 23, 2021 | HC Wainwright & Co. | maintain | — → Buy | $19 | 44% |
| Dec 16, 2020 | HC Wainwright & Co. | maintain | — → Buy | $22 | 44% |
| Aug 4, 2017 | Oppenheimer | initiate | — → Outperform | $3 | 52% |
| May 18, 2017 | Maxim Group | upgrade | Hold → Buy | $0 | 42% |
| Feb 13, 2017 | Rodman & Renshaw | initiate | — → Buy | $3 | 40% |
| Aug 12, 2016 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Mar 9, 2016 | JMP Securities | maintain | — → Market Outperform | $3 | 53% |
| Jun 22, 2015 | JMP Securities | initiate | — → Outperform | $5 | 53% |
| Jun 22, 2015 | JP Morgan | initiate | — → Market Outperform | $5 | 54% |
Price Target Trend
Mar 26, 2026 Latest: $22 Oct 24, 2026
EPS Estimates
+1y $-2.52
Lo: $-2.52 Hi: $-2.52
1 analysts ▲1
0q $-0.77
Lo: $-0.77 Hi: $-0.77
1 analysts ▲1
0y $-3.14
Lo: $-3.14 Hi: $-3.14
1 analysts ▲1
+1q $-0.80
Lo: $-0.80 Hi: $-0.80
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days